Linden Thomas Advisory Services’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.18M | Buy |
7,797
+66
| +0.9% | +$35.4K | 0.46% | 48 |
|
|
2025
Q1 | $3.25M | Buy |
7,731
+295
| +4% | +$124K | 0.42% | 51 |
|
|
2024
Q4 | $3.07M | Buy |
7,436
+169
| +2% | +$69.9K | 0.39% | 59 |
|
|
2024
Q3 | $3.67M | Buy |
7,267
+158
| +2% | +$79.8K | 0.5% | 31 |
|
|
2024
Q2 | $3.46M | Buy |
7,109
+931
| +15% | +$454K | 0.54% | 26 |
|
|
2024
Q1 | $3.34M | Buy |
6,178
+233
| +4% | +$126K | 0.54% | 24 |
|
|
2023
Q4 | $3.3M | Buy |
5,945
+328
| +6% | +$182K | 0.62% | 14 |
|
|
2023
Q3 | $2.46M | Buy |
5,617
+771
| +16% | +$337K | 0.55% | 19 |
|
|
2023
Q2 | $2.43M | Buy |
4,846
+144
| +3% | +$72.3K | 0.54% | 30 |
|
|
2023
Q1 | $2.35M | Buy |
4,702
+115
| +3% | +$57.5K | 0.58% | 28 |
|
|
2022
Q4 | $1.87M | Buy |
+4,587
| New | +$1.87M | 0.53% | 39 |
|